Browsing: China Medical System Holdings Ltd.

BioTech

CMS (867.HK; 8A8.SG): NDA for the Seasonal Allergic Rhinitis Indication of Class 1 Innovative Drug MG-K10 Accepted in China

By Marie JonesApril 23, 20260

China Medical System Holdings Limited (the Group or CMS) is pleased to announce that the New Drug Application (NDA) in…

BioTech

CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets

By Marie JonesJuly 21, 20250

On July 15 2025, to mark the successful secondary listing of China Medical System Holdings Limited (“CMS” or the “Group”)…

Hong Kong

Starting its Industrial Investment in Biotech Companies, China Medical System (HKG:867) has Accelerated its Flywheel of Innovation

By Marie JonesApril 26, 20210

China Medical System Holdings Limited (HKG:867) (CMS or the Company) has been active in the market this year. From the…

HealthCare

China Medical System Holdings Ltd. (0867. HK) Strategically Introduces Overseas Launched Blockbuster Innovative Products

By Marie JonesJuly 16, 20190

On June 27, 2019, China Medical System Holdings Ltd. (“China Medical System” or the “Company”) announced that the Company introduced…